N

NRX Pharmaceuticals
D

NRXP

2.70000
USD
0.11
(4.05%)
قبل الجلسة·2.79000USD+0.09000(+3.33%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
1,153
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
116,898,571
أصول ذات صلة

العنوان: NRX Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.